drugset

drugset / Trial / NCT00851500

A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

NCT00851500 ↗

Phase 2 Completed 210 enrolled Kowa Research Institute, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis.

Timeline

Start: 2009-02
Primary completion: 2011-06
Completion: 2011-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	K-604	Unknown	—	—

Indications